Embecta Shares Rise After Raising FY26 Adjusted EPS Outlook, 3Q Earnings Beat Estimates

Dow Jones08-07

Shares of Embecta rose after the global medical technology company raised its full-year outlook for adjusted earnings per share as third-quarter earnings beat estimates.

The stock was up 25% to $4.36 in recent trading, but has fallen 64% since the start of the year.

The company reported net income of $21.1 million, or 36 cents a share, compared with $45.5 million, or 78 cents a share, a year earlier.

Adjusted earnings a share were 56 cents a share. Analysts polled by FactSet expected 27 cents a share.

Revenue fell 8.1% to $271.1 million, driven by a decrease in U.S. sales. Analysts polled by FactSet expected $254.5 million.

For the full year, the company forecast revenue between $1.02 billion and $1.04 billion. It raised its adjusted earnings per share guidance to between $1.80 and $1.90 from $1.55 and $1.75.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment